Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity
Clinical trial NCT06427226 · RECRUITING
Trial details
- NCT number
- NCT06427226
- Sponsor
- Tanta University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2026-10-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.